in

Novel Vaccine Delivery Devices Market is estimated to be worth USD 1.5 billion in 2030

Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient

Roots Analysis is pleased to announce the publication of its recent study, titled, “Novel Vaccine Delivery Devices Market, 2019-2030”

The report features an extensive study of the current landscape and the likely future opportunities associated with novel vaccine delivery devices, over the next 10-12 years. Amongst other elements, the report includes:

  • A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers engaged in the development of novel vaccine delivery devices.
  • A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power and key product specifications.
  • An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of parameters.
  • A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future.
  • Elaborate profiles of prominent product developers engaged in the novel vaccine delivery devices domain (shortlisted on the basis of the number of pipeline products).
  • An analysis of the partnerships that have been established in this domain, in the recent past.
  • A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Request for Customization: https://www.rootsanalysis.com/reports/280/request-customization.html 

Global Novel Vaccine Delivery Devices (By Value)  

Type of Device

  • Electroporation-based Needle Free Injection Systems
  • Oral Delivery Systems
  • Nasal Delivery Systems
  • Jet Injectors
  • Microneedle Patches
  • Microinjectors

Route of Administration

  • Oral
  • Intramuscular
  • Intranasal
  • Intradermal
  • Subcutaneous

Type of Vaccines

  • Bivalent Oral Polio Vaccine
  • BCG Vaccine
  • DTP-HepB-Hib Vaccine
  • Pneumococcal Conjugate Vaccine
  • Influenza Vaccine
  • Measles Vaccine
  • Tetanus-Diphtheria Vaccine
  • Others

Key Geographical Region 

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Key companies covered in the report

  • 3M
  • Becton Dickinson
  • Consort Medical
  • D’Antonio Consultants International
  • Enesi Pharma
  • Ichor Medical
  • Iconovo
  • Inovio Pharmaceuticals
  • PharmaJet
  • Union Medico

Download PDF Sample: 

https://www.rootsanalysis.com/reports/280/request-sample.html     

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

This post was created with our nice and easy submission form. Create your post!

What do you think?

Written by Stella Wilson

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Ethereum Sets New ATH, Why ETH Could Continue Higher To $1,950

Ethereum Sets New ATH, Why ETH Could Continue Higher To $1,950

Binance Labs leads $2.4M investment round for Plasm Network

Binance Labs leads $2.4M investment round for Plasm Network » CryptoNinjas